The PI3K/Akt Pathway and Its Downstream Transcriptional Factors as Targets for Chemoprevention

E-ISSN： 1873-5576|7|4|305-316

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.4, 2007-06, pp. : 305-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

Current Cancer Drug Targets, Vol. 8, Iss. 3, 2008-05 ,pp. : 187-198

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors

Current Cancer Drug Targets, Vol. 8, Iss. 1, 2008-02 ,pp. : 7-18

Bentham Science Publishers

Access to resources Recommend Favorite

Salidroside attenuates myocardial ischemia–reperfusion injury via PI3K/Akt signaling pathway

By Xu Mao-Chun

Journal of Asian Natural Products Research, Vol. 15, Iss. 3, 2013-03 ,pp. : 244-252

Taylor & Francis Ltd

Access to resources Recommend Favorite

Impact of age and sex on response to ischemic preconditioning in the rat heart: differential role of the PI3K-AKT pathway 1

By Pancza Dezider

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 8, 2013-03 ,pp. : 640-647

NRC Research Press

Access to resources Recommend Favorite

PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1410-1416

Bentham Science Publishers

Access to resources Recommend Favorite